Reperio Health, a trailblazer in biometric health screening solutions, has announced a $14 million funding round led by Caduceus Capital Partners, LLC. This major investment supports Reperio’s mission to modernize preventive care by delivering on-demand, at-home health assessments with clinical-grade results.

Founded by Travis Rush, Reperio Health is redefining how individuals, employers, and health plans approach wellness screening - turning what used to be an in-clinic process into a convenient, technology-driven experience at home or in the office.

---

The Problem Reperio Solves

Health screenings have long been plagued by delays, accessibility gaps, and disengaged patients. Traditional wellness exams require in-person visits, scheduling conflicts, and time off work - barriers that lead to lower compliance rates and missed early diagnoses. For employers and payers, this results in rising healthcare costs and ineffective wellness initiatives.

Reperio flips that model. Its proprietary biometric screening kit is shipped directly to users and provides real-time results in under 30 minutes. The kit tests critical health markers such as cholesterol, glucose, blood pressure, height, weight, and more, using Bluetooth-connected medical devices paired with a sleek mobile app.

This means that for the first time, organizations can offer scalable, remote, clinical-grade health screenings without needing physical infrastructure or on-site professionals. And users can manage their health on their own terms, in their own space.

---

Why This Funding Matters Now

The timing of this $14M raise aligns with a massive shift in healthcare delivery. The rise of remote work, digital health tools, and value-based care models has created strong demand for decentralized, accessible, and personalized health services.

According to Grand View Research, the global at-home diagnostics market is projected to reach $8.5 billion by 2030, growing at a CAGR of 10.4%. In parallel, employer-sponsored wellness programs are increasingly seeking ways to quantify risk, engage employees, and reduce claims costs.

Reperio Health’s platform lives at this intersection. It enables on-demand biometric data collection that fuels personalized health strategies and proactive interventions - without burdening the user or the system.

Here’s the key insights for founders: Founders building in health tech must realize that the future isn’t telehealth vs. in-person - it’s infrastructure vs. interface. What Reperio gets right is that ownership of the biometric collection experience is the new frontier. Whoever controls the device, controls the data. And whoever controls the data, controls the relationship.

Too many startups try to wedge themselves into the care delivery layer, hoping to be “the next telehealth platform.” But the real opportunity lies in owning the entry point to clinical-grade data - at scale. Reperio’s self-contained ecosystem lets it gather insights, close care gaps, and trigger downstream clinical actions, all while sidestepping the infrastructure bottlenecks that limit traditional providers.

---

Meet the Founder: Travis Rush

Travis Rush, co-founder and CEO of Reperio Health, brings deep entrepreneurial experience in digital healthcare and consumer tech. Before launching Reperio, he founded companies like Sightbox, which was acquired by Johnson & Johnson Vision, and made notable strides in tele-optometry.

His vision for Reperio is clear: make biometric screenings accessible, engaging, and instant - without sacrificing clinical accuracy. Under his leadership, the company has grown into a trusted partner for employers, insurers, and health systems looking to reduce risk and boost engagement.

---

Market Opportunity: A New Era for Preventive Health

The U.S. spends over $4.3 trillion annually on healthcare, yet less than 3% is allocated to preventive care. This imbalance is costly: chronic conditions that go undetected early lead to higher downstream spending and worse health outcomes.

Reperio’s model addresses this gap by embedding health screenings into the environments where people already are - at home and at work. According to CDC data, only 8% of Americans receive all recommended preventive services, largely due to convenience and access issues. By reducing friction, Reperio is positioned to boost compliance, close risk gaps, and drive meaningful improvements in population health.

In addition, with employers facing rising insurance premiums and productivity loss from unmanaged conditions, Reperio’s platform is an attractive lever to reduce claims, improve morale, and meet wellness benchmarks.

---

What’s Next for Reperio Health?

With this new $14 million injection, Reperio Health plans to expand its commercial footprint, strengthen R&D efforts, and roll out new partnerships with enterprise clients and health plans across the U.S.

Future updates to the platform will likely include expanded testing panels, integrated coaching and referral pathways, and deeper analytics dashboards for employers and providers to act on real-time health data.

There’s also a broader vision at play: creating a frictionless bridge between health data and health action. Whether it’s nudging a user to see a cardiologist or helping a benefits team identify trends across a distributed workforce, Reperio is building the connective tissue modern healthcare desperately needs.

---